Revascularization for peripheral artery disease (angioplasty, stenting, bypass)

Revascularization is the group of procedures, open surgery or endovascular treatment, used on narrowed or blocked arteries in peripheral artery disease. Reviews describe bypass surgery and endovascular treatment (procedures done from inside the blood vessels) as the mainstream treatments. One review of endovascular options calls percutaneous transluminal angioplasty one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. The reviews also say the best choice between surgical and endovascular approaches is still debated, and one says not all people with chronic limb-threatening ischemia are suitable for revascularization.

Also called Peripheral artery revascularization · Endovascular treatment of peripheral artery disease · Bypass surgery for peripheral artery disease · Percutaneous transluminal angioplasty (PTA)

  • Intervention
  • In this atlas

Overview

Technical summary

MeSH Endovascular Procedures (D057510, broad): its scope note describes minimally invasive procedures done within the blood vessels, which is wider than peripheral artery treatment; the scope note does not mention bypass surgery. The record rests on that scope note and on three open-access reviews (PMC10095037, PMC12786405 and PMC7043107, all CC BY 4.0). The reviews' trial results, pooled effect estimates, device results and conclusions in favour of one approach are not repeated here, and the atlas states no recommendation of when to use either approach. Strategy page; the evidence recorded is descriptive and comes from reviews, with no study data of its own.

About this intervention

Type
Procedure
Mechanism
Bypass surgery is an operation. Endovascular treatment is done within the blood vessels and includes angioplasty and stents (reviews; MeSH defines endovascular procedures as minimally invasive procedures performed within the blood vessels).

Classification codes

  • MeSH id.nlm.nih.gov linked data, retrieved 2026-11-08, lastUpdated 2011-01-01 D057510

Claims and evidence

Context People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)

Recipient
Recipient not specified
Population
People with peripheral artery disease considered for treatment of blocked leg arteries, as the MeSH scope note and the reviews describe them. One review is about chronic limb-threatening ischemia and another about disease below the groin (infrainguinal); neither is a single study population.
Care setting
Vascular surgery and endovascular treatment, as the reviews describe them.
Geography
Not stated for the reviews as a whole.
Life stage
Adults are implied but not stated. This record makes no statement about pregnancy, newborns or children.
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (reviews of treatment approaches; follow-up periods of individual studies are not recorded).
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Peripheral artery disease treated with surgery or endovascular procedures
Excluded
None stated
  • Description Evidence synthesis Certainty not assessed

    MeSH describes endovascular procedures as minimally invasive procedures performed within the blood vessels. A 2025 systematic review (Journal of Clinical Medicine) calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease and says the choice of treatment varies and the best approach has been a subject of ongoing controversy; it also says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data. A 2020 review (F1000Research) describes percutaneous transluminal angioplasty as one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. A 2023 review of chronic limb-threatening ischemia says there is still a lack of consensus on the best treatment strategy and that not all patients are suitable for revascularization.

    Applies to Recipient not specified People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)

    Certainty method
    Not assessed
    Limitations
    Reviews that describe approaches and their debate. Pooled effect estimates, trial results, device results and each review's own conclusion about which approach to prefer are not repeated and not assessed, and the atlas makes no recommendation. The sources do not define bypass surgery beyond naming it, and they cover different parts of the leg arteries.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (8)
    1. Background Chronic Limb-Threatening Ischemia and the Need for Revascularization

      Publication · Journal of Clinical Medicine · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2023;12), fetched 2026-11-18. A narrative review. Used for what chronic limb-threatening ischemia is, the hemodynamic measures named in its diagnosis, and the limits the review states on choosing a revascularization strategy; the trial results, classification thresholds and guideline details it discusses are not used. · PMCID: PMC10095037 · PMID: 37048765 · DOI: 10.3390/jcm12072682

      Locator
      Abstract, Background, sentence 4
      How it applies
      In chronic limb-threatening ischemia the review says there is still a lack of consensus on the best treatment strategy.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    2. Supports Chronic Limb-Threatening Ischemia and the Need for Revascularization

      Publication · Journal of Clinical Medicine · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2023;12), fetched 2026-11-18. A narrative review. Used for what chronic limb-threatening ischemia is, the hemodynamic measures named in its diagnosis, and the limits the review states on choosing a revascularization strategy; the trial results, classification thresholds and guideline details it discusses are not used. · PMCID: PMC10095037 · PMID: 37048765 · DOI: 10.3390/jcm12072682

      Locator
      Abstract, Results, sentence 2 (part)
      How it applies
      The review says not all patients with chronic limb-threatening ischemia are suitable for revascularization.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    3. Supports MeSH scope note for descriptor D057510 (Endovascular Procedures)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0537674 of descriptor D057510, fetched 2026-11-08. The scope note is on this concept record, not on the descriptor record. · MeSH: M0537674

      Locator
      scopeNote.@value, sentence 1
      How it applies
      MeSH: endovascular procedures are minimally invasive procedures performed within the blood vessels.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      3237ee241ca87299b9cc6f99d562e52f5e731dd23f37dbdaf183f420a0f6fc54
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, fetched 2026-11-08, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-08 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    4. Supports Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

      Publication · Journal of Clinical Medicine · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used. · PMCID: PMC12786405 · PMID: 41517252 · DOI: 10.3390/jcm15010002

      Locator
      1. Introduction, para 2, sentence 1
      How it applies
      The review calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    5. Supports Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

      Publication · Journal of Clinical Medicine · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used. · PMCID: PMC12786405 · PMID: 41517252 · DOI: 10.3390/jcm15010002

      Locator
      1. Introduction, para 2, sentence 2 (part)
      How it applies
      The review says the choice of treatment varies and the best approach has been a subject of ongoing controversy.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    6. Background Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

      Publication · Journal of Clinical Medicine · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (J Clin Med 2025;15), fetched 2026-11-18. A systematic review and meta-analysis. Used only for how the review describes the mainstream treatments for peripheral artery disease and its statement that the best approach is debated; its pooled odds ratios, hazard ratios and its conclusion are not used. · PMCID: PMC12786405 · PMID: 41517252 · DOI: 10.3390/jcm15010002

      Locator
      Abstract, Objectives, sentence 1
      How it applies
      The review says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    7. Supports Recent advances in endovascular treatment of peripheral arterial disease

      Publication · F1000Research · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (F1000Research 2020;9), fetched 2026-11-18. A review article. Used only for what angioplasty and stents are in endovascular treatment of peripheral arterial disease; device results and regulatory comments in the review are not used. · PMCID: PMC7043107 · PMID: 32148765 · DOI: 10.12688/f1000research.20398.1

      Locator
      Percutaneous transluminal angioplasty, para 1, sentence 1 (end)
      How it applies
      Percutaneous transluminal angioplasty is described as one of the mainstays of endovascular therapy.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    8. Supports Recent advances in endovascular treatment of peripheral arterial disease

      Publication · F1000Research · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (F1000Research 2020;9), fetched 2026-11-18. A review article. Used only for what angioplasty and stents are in endovascular treatment of peripheral arterial disease; device results and regulatory comments in the review are not used. · PMCID: PMC7043107 · PMID: 32148765 · DOI: 10.12688/f1000research.20398.1

      Locator
      Endovascular stents, para 1, sentence 2
      How it applies
      Stents have evolved to include bare metal stents, covered stents and drug-eluting stents.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:revascularization-for-peripheral-artery-disease-angioplasty-stenting-bypass
Content hash
63115c116197cd6d66922008f9e5f11b0d7c2c0469861b80834f12479341ea47